Page last updated: 2024-08-17

adenosine diphosphate and Non-ST Elevated Myocardial Infarction

adenosine diphosphate has been researched along with Non-ST Elevated Myocardial Infarction in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Holm, M; Rihan Hye, S; Tornvall, P; van der Linden, J; Westerberg, J	1

Trials

1 trial(s) available for adenosine diphosphate and Non-ST Elevated Myocardial Infarction

Article	Year
Ticagrelor pharmacokinetics and pharmacodynamics in patients with NSTEMI after a 180-mg loading dose. Platelets, 2017, Volume: 28, Issue:7 Topics: Adenosine; Adenosine Diphosphate; Aged; Biotransformation; Blood Platelets; Coronary Artery Disease; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Sweden; Ticagrelor	2017

Article

Year

Ticagrelor pharmacokinetics and pharmacodynamics in patients with NSTEMI after a 180-mg loading dose.

Platelets, 2017, Volume: 28, Issue:7

Topics: Adenosine; Adenosine Diphosphate; Aged; Biotransformation; Blood Platelets; Coronary Artery Disease; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Sweden; Ticagrelor

2017